Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times

British Journal of Haematology

Volumn 156, Issue 2, 2012, Pages 225-233

  Wahlin, Björn E ^a   Yri, Olav E ^b,c   Kimby, Eva ^a   Holte, Harald ^b   Delabie, Jan ^b   Smeland, Erlend B ^b,c   Sundström, Christer ^d   Christensson, Birger ^a   Sander, Birgitta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anthracyclines; Follicular lymphoma; Grade; Rituximab; World Health Organization

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; FLUDARABINE; RITUXIMAB;

ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; CANCER GRADING; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 84155188820     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08942.x     Document Type: Article

References (27)

1. Anderson, J.R., Vose, J.M., Bierman, P.J., Weisenberger, D.D., Sanger, W.G., Pierson, J., Bast, M. & Armitage, J.O. (1993) Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. Journal of Clinical Oncology, 11, 218-224.
2. Bartlett, N.L., Rizeq, M., Dorfman, R.F., Halpern, J. & Horning, S.J. (1994) Follicular large-cell lymphoma: intermediate or low grade? Journal of Clinical Oncology, 12, 1349-1357.
3. van Besien, K. (2009) Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy. Hematology, 2009, 610-618.
4. Bosga-Bouwer, A.G., van den Berg, A., Haralambieva, E., de Jong, D., Boonstra, R., Kluin, P., van den Berg, E. & Poppema, S. (2006) Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? Human Pathology, 37, 528-533.
5. Chau, I., Jones, R., Cunningham, D., Wotherspoon, A., Maisey, N., Norman, A.R., Jain, P., Bishop, L., Horwich, A. & Catovsky, D. (2003) Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? British Journal of Cancer, 89, 36-42.
6. Federico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., Cortelazzo, S., Martinelli, G., Martelli, M., Rigacci, L., Arcaini, L., Di Raimondo, F., Merli, F., Sabattini, E., McLaughlin, P. & Solal-Celigny, P. (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. Journal of Clinical Oncology, 27, 4555-4562.
7. Feller, A.C., Diebold, J. & Lennert, K. (2004) Centroblastic lymphoma. In: Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas, pp. 80-85. Springer-Verlag, Berlin.
8. Gallagher, C.J., Gregory, W.M., Jones, A.E., Stansfeld, A.G., Richards, M.A., Dhaliwal, H.S., Malpas, J.S. & Lister, T.A. (1986) Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology, 4, 1470-1480.
9. Ganti, A.K., Weisenburger, D.D., Smith, L.M., Hans, C.P., Bociek, R.G., Bierman, P.J., Vose, J.M. & Armitage, J.O. (2006) Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. Annals of Oncology, 17, 920-927.
10. Hans, C.P., Weisenburger, D.D., Vose, J.M., Hock, L.M., Lynch, J.C., Aoun, P., Greiner, T.C., Chan, W.C., Bociek, R.G., Bierman, P.J. & Armitage, J.O. (2003) A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood, 101, 2363-2367.
11. Harris, N.L., Swerdlow, S.H., Jaffe, E.S., Ott, G., Nathwani, B.N., de Jong, D., Yoshino, T. & Spagnolo, D. (2008) Follicular lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman ), pp. 220-226. IARC, Lyon.
12. Horn, H., Schmelter, C., Leich, E., Salaverria, I., Katzenberger, T., Ott, M.M., Kalla, J., Romero, M., Siebert, R., Rosenwald, A. & Ott, G. (2011) Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica, 96, 1327-1334.
13. Horning, S.J., Weiss, L.M., Nevitt, J.B. & Warnke, R.A. (1987) Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphoma. Cancer, 59, 1470-1474.
14. Hsi, E.D., Mirza, I., Lozanski, G., Hill, J., Pohlman, B., Karafa, M.T. & Coupland, R. (2004) A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Archives of Pathology and Laboratory Medicine, 128, 863-868.
15. Katzenberger, T., Ott, G., Klein, T., Kalla, J., Muller-Hermelink, H.K. & Ott, M.M. (2004) Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. American Journal of Pathology, 165, 481-490.
16. Klapper, W., Hoster, E., Rolver, L., Schrader, C., Janssen, D., Tiemann, M., Bernd, H.W., Determann, O., Hansmann, M.L., Moller, P., Feller, A., Stein, H., Wacker, H.H., Dreyling, M., Unterhalt, M., Hiddemann, W. & Ott, G. (2007) Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. Journal of Clinical Oncology, 25, 3330-3336.
17. Martin, A.R., Weisenburger, D.D., Chan, W.C., Ruby, E.I., Anderson, J.R., Vose, J.M., Bierman, P.J., Bast, M.A., Daley, D.T. & Armitage, J.O. (1995) Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood, 85, 3671-3678.
18. Miller, T.P., LeBlanc, M., Grogan, T.M. & Fisher, R.I. (1997) Follicular lymphomas: do histologic subtypes predict outcome? Hematology/oncology Clinics of North America, 11, 893-900.
19. Ott, G., Katzenberger, T., Lohr, A., Kindelberger, S., Rudiger, T., Wilhelm, M., Kalla, J., Rosenwald, A., Muller, J.G., Ott, M.M. & Muller-Hermelink, H.K. (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood, 99, 3806-3812.
20. Piccaluga, P.P., Califano, A., Klein, U., Agostinelli, C., Bellosillo, B., Gimeno, E., Serrano, S., Sole, F., Zang, Y., Falini, B., Zinzani, P.L. & Pileri, S.A. (2008) Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica, 93, 1033-1038.
21. Rodriguez, J., McLaughlin, P., Hagemeister, F.B., Fayad, L., Rodriguez, M.A., Santiago, M., Hess, M., Romaguera, J. & Cabanillas, F. (1999) Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood, 93, 2202-2207.
22. Shustik, J., Quinn, M., Connors, J.M., Gascoyne, R.D., Skinnider, B. & Sehn, L.H. (2011) Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Annals of Oncology, 22, 1164-1169.
23. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J.O., Arranz-Saez, R., Au, W.Y., Bellei, M., Brice, P., Caballero, D., Coiffier, B., Conde-Garcia, E., Doyen, C., Federico, M., Fisher, R.I., Garcia-Conde, J.F., Guglielmi, C., Hagenbeek, A., Haioun, C., LeBlanc, M., Lister, A.T., Lopez-Guillermo, A., McLaughlin, P., Milpied, N., Morel, P., Mounier, N., Proctor, S.J., Rohatiner, A., Smith, P., Soubeyran, P., Tilly, H., Vitolo, U., Zinzani, P.L., Zucca, E. & Montserrat, E. (2004) Follicular lymphoma international prognostic index. Blood, 104, 1258-1265.
24. The Non-Hodgkin's Lymphoma Classification Project. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 89, 3909-3918.
25. Wahlin, B.E., Sander, B., Christensson, B. & Kimby, E. (2007) CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clinical Cancer Research, 13, 388-397.
26. Wahlin, B.E., Aggarwal, M., Montes-Moreno, S., Gonzalez, L.F., Roncador, G., Sanchez-Verde, L., Christensson, B., Sander, B. & Kimby, E. (2010) A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Clinical Cancer Research, 16, 637-650.
27. Wendum, D., Sebban, C., Gaulard, P., Coiffier, B., Tilly, H., Cazals, D., Boehn, A., Casasnovas, R.O., Bouabdallah, R., Jaubert, J., Ferrant, A., Diebold, J., de Mascarel, A. & Gisselbrecht, C. (1997) Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 15, 1654-1663.